Pharmaceutical manufacturing facility with stainless steel tanks and process piping requiring professional derouging services
GMP-Compliant Rouge Removal

Professional Derouging Services for Pharmaceutical Systems

Remove Type I, II, and III rouge contamination from WFI loops, clean steam systems, and process vessels. EDTA and citric acid derouging with complete re-passivation per ASTM A967 and GMP documentation.

99%
Rouge Removal
24-48h
Typical Cycle
200+
Facilities Served
Heavy rouge contamination inside pharmaceutical stainless steel tank before professional derouging treatment
Clean passivated stainless steel tank interior after CXP professional derouging and passivation treatment
ASTM Compliant
A967 + A380
Scroll
ASTM A967 Compliant
ASTM A380 Cleaning
ASME BPE Standards
FDA 21 CFR 211
EU GMP Annex 1
IQ/OQ Documentation
100% Owner-Operated
Technical Foundation

What Is Rouge & Why It Matters

Rouge is iron oxide contamination that forms on stainless steel when the protective chromium oxide passive layer is compromised—causing progressive system degradation and regulatory failures.

Rouge Is Not Rust—It's Complex Iron Oxide Contamination

Rouge is a mixture of iron oxides (Fe₂O₃, Fe₃O₄, FeO) that develops on stainless steel when the protective chromium oxide passive layer is compromised through heat exposure, aggressive CIP chemistry, contamination, or incomplete passivation.

Unlike surface rust, rouge is electrochemically generated from the stainless steel substrate itself. The iron content within 316L and 304 alloys oxidizes when protective chromium depletion occurs—creating adherent iron oxide deposits that shed particles into process streams.

Professional derouging requires understanding of ASTM A380 cleaning chemistry, iron chelation mechanisms, and proper ASTM A967 re-passivation to restore long-term corrosion resistance.

⚠️ Critical Impact on GMP Operations
Rouge contamination introduces particulates into WFI systems, causes elevated endotoxin levels, creates non-cleanable surfaces harboring biofilm, and triggers FDA 483 observations. Pharmaceutical facilities must maintain particle counts below 10 particles/mL (≥10 µm) per USP requirements.
Rouge corrosion contamination on pharmaceutical stainless steel heat exchanger tubes requiring professional derouging treatment
Contamination Type
Type II Rouge on Heat Exchanger
Close-up of iron oxide corrosion debris and metal particle contamination on stainless steel surface
🔴
Particle Contamination
Rouge sheds iron oxide particles (1-100 µm) into process streams, failing pharmaceutical particle count specifications.
🦠
Biofilm Harboring
Rough iron oxide surfaces provide ideal sites for bacterial adhesion, preventing effective CIP/SIP sanitization.
⚗️
Product Degradation
Free iron catalyzes oxidation reactions in API solutions and biologics, causing stability failures and reduced shelf life.
📉
System Performance
Rouge buildup restricts flow, reduces heat transfer efficiency, and accelerates equipment degradation.
Rouge Classification

Three Types of Rouge Contamination

Understanding rouge type determines optimal derouging chemistry and process parameters. CXP assesses contamination severity with ferroxyl testing before recommending treatment protocols.

I

Type I Rouge

Black Magnetite (Fe₃O₄)

Black magnetic iron oxide formed under high-temperature conditions in clean steam systems, SIP cycles, and heat-exposed equipment. Most adherent and difficult to remove—requires aggressive EDTA chemistry.

Characteristics

  • Black to dark gray appearance
  • Magnetic properties
  • Forms at 250-400°F (120-200°C)
  • Tight adherence to substrate
  • Requires EDTA-enhanced derouging
II

Type II Rouge

Dark Brown Hematite (Fe₂O₃)

Dark brown to reddish-brown iron oxide formed in WFI/PW systems under moderate temperature and oxygen exposure. Most common rouge type in pharmaceutical water distribution systems.

Characteristics

  • Dark reddish-brown color
  • Non-magnetic
  • Forms at 150-200°F (65-95°C)
  • Moderate adherence
  • Responds to citric or EDTA
III

Type III Rouge

Light Red Ferric Oxide

Light red to orange-brown loose iron oxide formed under ambient conditions from contamination or failed passivation. Least adherent type—typically from external iron source contamination.

Characteristics

  • Light red to orange appearance
  • Loosely adhered
  • Forms below 140°F (60°C)
  • Easy mechanical removal
  • Simple citric acid derouging

Ready to Eliminate Rouge From Your Systems?

CXP deploys nationwide with mobile derouging units, pharmaceutical-grade chemistry, and complete GMP documentation. Zero FDA findings across 200+ facilities.

Root Cause Analysis

What Causes Rouge Formation?

Rouge develops when multiple factors compromise the stainless steel passive layer. Understanding root causes helps prevent recurrence after derouging treatment.

01

Incomplete Passivation

Improper initial passivation leaves free iron embedded in the surface. Without complete iron removal and chromium oxide restoration, rouge begins forming immediately during system startup.

02

Aggressive CIP Chemistry

High-chloride cleaners (>25 ppm Cl⁻) and extreme pH solutions attack the passive layer, exposing underlying iron to oxidation. Review your CIP system protocols to prevent chemical damage.

03

Heat-Induced Oxidation

Clean steam, SIP cycles above 250°F, and hot WFI distribution accelerate iron oxide formation. Extended exposure converts protective chromium layers to rouge.

04

Carbon Steel Contamination

Contact with carbon steel tools, fittings, or contaminated water introduces free iron particles that nucleate rouge formation. Proper commissioning protocols prevent this.

05

Insufficient Rinsing

Inadequate rinse cycles after cleaning leave iron-bearing residues that oxidize. Conductivity spikes indicate incomplete rinse protocols.

06

Poor Water Quality

High iron content in makeup water (>0.3 ppm Fe), elevated chlorides, or poor pretreatment introduces contaminants that deposit on surfaces and oxidize to rouge over time.

Real Results

Derouging Transformation

CXP derouging services completely remove rouge contamination and restore stainless steel to pristine, properly passivated condition with verified cleanliness documentation.

Before Derouging
Corroded stainless steel pipe interior showing heavy rouge contamination with iron oxide deposits before CXP derouging treatment

Heavy Type II Rouge

Dark reddish-brown deposits on electropolished surfaces. Particle counts exceeding 500/mL—well above USP acceptance limits.

After Derouging
Same pharmaceutical tank interior after CXP EDTA derouging showing clean mirror-finish electropolished stainless steel

Complete Restoration

Surface restored to original electropolished condition. Re-passivated per ASTM A967, particle counts <5/mL, conductivity <1.1 µS/cm.

Complete Workflow

CXP Derouging Process

Six-phase methodology ensuring complete rouge removal, surface restoration, and GMP-compliant passivation with full documentation.

1

Inspection & Testing

Visual assessment, ferroxyl testing, rouge type identification, surface documentation

2

Alkaline Degrease

Remove oils and organics per ASTM A380 for optimal acid contact

3

Derouging Cycle

EDTA or citric acid circulation at 140-160°F for iron oxide dissolution

4

Neutralization

pH adjustment and acid residue removal to prevent flash rusting

5

Re-Passivation

Citric passivation per ASTM A967 to restore chromium oxide layer

6

Verification

Ferroxyl test, conductivity, particle count, surface inspection, GMP documentation

CXP technician performing professional derouging treatment on stainless steel pharmaceutical process tank
On-Site Execution
Mobile Derouging Unit in Operation
Technical Specifications

Derouging Chemistry & Parameters

CXP uses pharmaceutical-grade chelating agents specifically formulated for iron oxide removal while protecting the stainless steel substrate.

Critical Parameters

Citric Acid 4-10% w/w
EDTA Concentration 2-5% w/w
Temperature 140-160°F
Contact Time 2-8 hours
Target pH 2.0-3.5
Final Conductivity <1.3 µS/cm

Chemistry Selection Guide

Citric acid is preferred for Type II and Type III rouge due to excellent iron-chelating properties and safe handling. EDTA is used for stubborn Type I magnetite rouge requiring enhanced chelation strength.

Chemistry Concentration Temperature Best For
Citric Acid 4-10% w/w 140-150°F Type II, III rouge
EDTA Enhanced 2-5% EDTA 150-160°F Type I magnetite
Hybrid Citric/EDTA 6% + 3% 145-155°F Mixed rouge types
Nitric Acid 10-20% HNO₃ 120-140°F Severe cases only
Quality Assurance

Derouging Verification & Testing

Multiple verification methods confirm complete rouge removal, proper passivation restoration, and system readiness for GMP operation.

🔬

Ferroxyl Test

Potassium ferricyanide detects free iron. Negative result confirms complete iron removal and proper passivation.

💧

Water Break Test

Continuous water film indicates uniform passivation. Water beading signals incomplete treatment.

Conductivity

Final rinse must be <1.3 µS/cm per USP <645>. Elevated readings require additional rinsing.

🔍

Visual Inspection

White-light inspection confirms rouge removal, uniform surface, no discoloration on welds or HAZ.

🧪

pH Verification

Final rinse pH must stabilize 6.5-7.5 with no drift over 15 minutes indicating complete neutralization.

📊

Particle Count

USP <788> testing: <10 particles/mL (≥10 µm), <2 particles/mL (≥25 µm) for pharmaceutical acceptance.

GMP Compliance

Complete Documentation Packages

FDA-compliant derouging documentation supporting validation, regulatory inspections, and quality system requirements.

📋

Standard Deliverables

  • Derouging protocol (approved & executed)
  • Batch production records with signatures
  • Chemical concentration verification
  • Time/temperature logs
  • pH and conductivity trending
  • Ferroxyl test results with photos
  • Particle count reports
  • Chemical lot traceability

Optional IQ/OQ Packages

  • Installation Qualification (IQ)
  • Operational Qualification (OQ)
  • Equipment calibration certificates
  • Operator training records
  • Deviation reports (if applicable)
  • 21 CFR Part 11 electronic records
  • Validation summary reports
  • Final system turnover package

Audit-Ready Documentation Standard

All CXP documentation is prepared to withstand FDA 483 observations, EU GMP inspections, and international audits. Zero findings related to derouging across pharmaceutical, biotech, and medical device facilities.

Common Questions

Derouging FAQs

How long does a typical derouging cycle take?
+

Typical cycles range 24-72 hours depending on severity. Light Type III rouge: 24-36 hours with citric acid. Heavy Type I magnetite: 48-72 hours with EDTA. CXP provides detailed timeline estimates during project scoping.

Is derouging safe for electropolished stainless steel?
+

Yes. Citric acid and EDTA selectively remove iron oxide while protecting the chromium-rich passive layer. CXP maintains strict temperature control and optimized chemistry to prevent etching. Post-derouging passivation often improves surface finish.

Can rouge come back after derouging?
+

Rouge can return if root causes aren't addressed. After CXP derouging and re-passivation, systems remain rouge-free when proper protocols are maintained. CXP provides operating procedure recommendations to prevent recurrence.

What's the difference between derouging and passivation?
+

Derouging removes existing rouge contamination using chelating agents. Passivation creates/restores the protective chromium oxide layer. Derouging is always followed by re-passivation. New equipment only needs passivation; contaminated equipment needs derouging first.

Do you need to shut down the system for derouging?
+

Yes, systems must be offline. CXP minimizes downtime through efficient planning, rapid mobilization, and parallel processing. Derouging is typically scheduled during maintenance shutdowns or validation campaigns.

CXP Advantage

Why CXP for Derouging

👤

Owner-Led Execution

Direct owner involvement ensures technical precision and uncompromising quality on every project.

🔬

Chemistry Expertise

Deep understanding of rouge formation and iron chelation enables optimal process selection.

🚛

Mobile Rapid Response

Self-contained mobile units with integrated heating and monitoring for fast deployment nationwide.

📋

GMP Documentation

FDA-compliant packages supporting pharmaceutical validation and regulatory inspections.

🛡️

Zero-Compromise Safety

Perfect 10+ year safety record across 200+ facilities. Comprehensive risk assessment on every project.

🏆

Proven Results

Hundreds of successful derouging projects with zero FDA inspection findings related to our procedures.

Need Professional Derouging Services?

CXP Solutions provides complete derouging, rouge removal, and stainless steel restoration for pharmaceutical, biotech, and industrial facilities nationwide.

CXP Solutions mobile passivation and derouging equipment
Scroll to Top